UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 4, 2024

 

ASP Isotopes Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

 

001-41555

 

87-2618235

(State or other jurisdiction of

incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

601 Pennsylvania Avenue NW,

South BuildingSuite 900

WashingtonDC

 

20004

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: (202756-2245

 

 Not Applicable

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Ticker symbol(s)

 

Name of each exchange on which registered

Common Stock, par value $0.01

 

ASPI

 

The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act    

 

 

 

 

Item 8.01. Other Events.

 

On November 4, 2024, ASP Isotopes Inc. (the “Company”) announced the closing of the Company’s previously announced underwritten public offering of shares of its common stock.  The Company sold 2,754,250 shares of its common stock, which reflects the exercise in full by the underwriter of its option to purchase up to 359,250 additional shares of common stock, at a public offering price of $6.75 per share, less underwriting discounts and commissions.  The total gross proceeds to the Company from the offering (before deducting the underwriting discounts and commissions and offering expenses) were $18.6 million.

 

A copy of the Company’s press release announcing the closing of its public offering and full exercise of underwriter’s option to purchase additional shares is attached as Exhibit 99.1 hereto and is incorporated herein by reference.

 

Item 9.01. Financial Statements and Exhibits.

 

Exhibit No.

 

Description

99.1

 

Press Release, dated November 4, 2024, of ASP Isotopes Inc. announcing the closing of its public offering and full exercise of underwriter’s option to purchase additional shares.

104

 

Cover Page Interactive Date File (embedded within the Inline XBRL document)

 

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

ASP ISOTOPES INC.

 

 

 

 

Date: November 4, 2024

By:

/s/ Paul Mann

 

 

Name:

Paul Mann

 

 

Title:

Chief Executive Officer

 

 

 

3

 

nullv3.24.3
Cover
Nov. 04, 2024
Cover [Abstract]  
Entity Registrant Name ASP Isotopes Inc.
Entity Central Index Key 0001921865
Document Type 8-K
Amendment Flag false
Entity Emerging Growth Company true
Document Period End Date Nov. 04, 2024
Entity Ex Transition Period false
Entity File Number 001-41555
Entity Incorporation State Country Code DE
Entity Tax Identification Number 87-2618235
Entity Address Address Line 1 601 Pennsylvania Avenue NW
Entity Address Address Line 2 South Building
Entity Address Address Line 3 Suite 900
Entity Address City Or Town Washington
Entity Address State Or Province DC
Entity Address Postal Zip Code 20004
City Area Code 202
Local Phone Number 756-2245
Security 12b Title Common Stock, par value $0.01
Trading Symbol ASPI
Security Exchange Name NASDAQ
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false

ASP Isotopes (NASDAQ:ASPI)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more ASP Isotopes Charts.
ASP Isotopes (NASDAQ:ASPI)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more ASP Isotopes Charts.